TYLENOL PM
- Product NDC
- 50580-833
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50580-833-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50580-833-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50580-833-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50580-833-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50580-833-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50580-833-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50580-833-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50580-833-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50580-833-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 50580-833-01 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Reliever | ACETAMINOPHEN | Walmart Inc. | 24d191ca-a0c4-e1a8-e063-6394a90a7a2a | 2025-07-16 | Warnings | M013 |
| EXTRA STRENGTH HEADACHE RELIEF | ACETAMINOPHEN ASPIRIN CAFFEINE | WAL-MART STORES INC | d97073cd-b5d7-8c09-e053-2a95a90a8938 | 2025-07-16 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | BETTER LIVING BRANDS LLC. | f3005d0c-424e-0ab3-e053-2995a90a1c10 | 2025-07-16 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 397fa6e1-37b2-8f51-e063-6394a90a7b94 | 2025-07-16 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 39800c27-f39f-cd60-e063-6394a90acd55 | 2025-07-16 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 397f2b63-733e-5b44-e063-6394a90a9718 | 2025-07-16 | Warnings | M013 |
| EXTRA STRENGTH PAIN RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | BETTER LIVING BRANDS, LLC | eb6026d5-d88a-f6b3-e053-2a95a90a5b20 | 2025-07-15 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Safeway | f9597abc-3f01-4b94-8078-228e0b74677e | 2025-07-15 | Warnings | M013 |
| Berkley and Jensen Pain Relief | ACETAMINOPHEN | BJWC | d3ee3341-93b8-487c-921e-2892d213efbb | 2025-07-15 | Warnings | M013 |
| EXTRA PAIN RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | TIME CAP LABS | 59482917-f80b-4bed-9218-068b35366eb3 | 2025-07-11 | Warnings | M013 |
| Up and Up Childrens acetaminophen | ACETAMINOPHEN | Target Corporation | 25a476a4-9969-49b3-94bf-b076bada4cea | 2025-07-10 | Warnings | M013 |
| Tylenol Extra Strength Caplet | ACETAMINOPHEN | Jones Healthcare Group - Packaging Services, Inc | fba711c1-4e69-49b0-8994-97c455aebcb2 | 2025-07-09 | Warnings | M013 |
| good sense pain relief | ACETAMINOPHEN | L. Perrigo Company | af7ae548-38ad-41d5-b1cb-761cd2e386d3 | 2025-07-08 | Warnings | M013 |
| topcare pain relief | ACETAMINOPHEN | Topco Associates LLC | 6aca88df-d3b5-4a60-b23b-1e66dc41ee7b | 2025-07-08 | Warnings | M013 |
| equate childrens pain and fever | ACETAMINOPHEN | Wal-Mart Stores Inc | f15037a5-4e43-4dd6-93b8-b37a1cc22cd6 | 2025-07-07 | Warnings | M013 |
| Childrens Acetaminophen Oral Liquid Grape Flavor | ACETAMINOPHEN | AARNA USA INC. | 39347f5d-2d3c-0c23-e063-6294a90a3a46 | 2025-07-05 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | Meijer Distribution Inc | be841460-98b4-4448-a494-09ff161fd131 | 2025-07-02 | Warnings | M013 |
| Adult Low Dose Aspirin | ASPIRIN | Advanced Rx LLC | ad0d6a5c-eee9-406c-8d7f-1df9b45f5340 | 2025-07-02 | Warnings | M013 |
| EXTRA STRENGHT HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Lil' Drug Store Products, Inc. | ec04eb5d-96c0-ddb4-e053-2a95a90a4a92 | 2025-07-02 | Warnings | M013 |
| Acetaminophen and Diphenhydramine Hydrochloride | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Bi-Mart | 70084eea-1480-4c46-b849-4c779319cb74 | 2025-07-02 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |